Work

Ticagrelor vs clopidogrel on vein graft patency in patients with diabetes undergoing coronary artery bypass grafting

Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUNDPatients with type 2 diabetes mellitus (T2DM) undergoing coronary artery bypass grafting (CABG) are at high risk of saphenous vein graft (SVG) failure.The optimal antiplatelet therapy for maintaining SVG patency in this population remains uncertain. AIMTo investigate whether ticagrelor plus aspirin is associated with better 5-year SVG patency than clopidogrel plus aspirin in patients with T2DM who undergo CABG. CONCLUSIONAmong 5-year survivors with T2DM who underwent CABG, ticagrelor plus aspirin was associated with better 5-year SVG grade A patency than clopidogrel plus aspirin.This is an uncontrolled observational association, and the estimand is limited to patients who survived to the 5-year CTA.The MACE and BE are inconclusive.These findings do not establish causality, superiority, or equivalent safety.Adequately powered, multicenter, prospective randomized controlled trials are required.
Institution: Changhai Hospital
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7236083619
FWCI:
Cites: 31
Cited by:
Related to: 10